US Patent Issued to ZINCURE on July 1 for "Pharmaceutical composition for treating multiple sclerosis on basis of AMPK inhibitory function and zinc homeostasis control function" (South Korean Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,335, issued on July 1, was assigned to ZINCURE CORP. (Seoul, South Korea).

"Pharmaceutical composition for treating multiple sclerosis on basis of AMPK inhibitory function and zinc homeostasis control function" was invented by Yang-Hee Kim (Seoul, South Korea), Jae Won Eom (Guri-si, South Korea), Sang Won Suh (Chuncheon-si, South Korea) and Bo Young Choi (Chuncheon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a pharmaceutical composition for treating multiple sclerosis based on AMPK inhibitory function and zinc homeostasis controlling function that effectively treats multiple sclerosis due to its excel...